Gefticip Tablets Cipla About
Capitalize on this grand deal with Gefticip Tablets by Cipla, designed for those seeking spectacular results in the fight against Non-Small Cell Lung Cancer. Each 250 mg film-coated tablet delivers outstanding efficacy, positioning it at the forefront of oral anticancer agents. Supplied in a secure 1X10 blister pack, Gefticip promises a sterling experience with each dose. Best price offers are available for commercial, clinical, or personal use, making it an exceptional choice for professionals and patients. Prescription is required for this API product, manufactured to top standards by Cipla, India.
Advanced Application & Extensive Features of Gefticip Tablets Cipla
Gefticip Tablets are intended for oral administration, ensuring effortless patient compliance in hospital, clinical, or personal settings. Each film-coated tablet contains a precise 250 mg dose of Gefitinib, guaranteed odorless and easy to swallow. Notable for its extended 24-month shelf life, blister-pack protection, and reliable oral anticancer feature, Gefticip is the perfect option for healthcare professionals and exporters aiming for consistent, top-quality outcomes in cancer management.
Swift Delivery, Reliable Certifications & Easy Payment Terms for Gefticip Tablets
Experience swift order processing and prompt delivery when you purchase Gefticip Tablets Cipla. Orders are efficiently charged, prepared, and handed over to trusted couriers within stipulated timelines. Backed by Cipla's sterling certifications, every batch meets stringent quality standards. Flexible payment terms accommodate diverse client requirements, ensuring seamless and transparent transactions. Whether you're an exporter, supplier, or clinical buyer in India, rest assured that your Gefticip order will be handled with utmost professionalism from start to finish.
FAQ's of Gefticip Tablets Cipla:
Q: How should Gefticip Tablets Cipla be administered for best results?
A: Gefticip Tablets Cipla are administered orally. Follow your healthcare provider's instructions regarding dosage and schedule, typically one 250 mg tablet daily, with or without food.
Q: What is the main benefit of using Gefticip Tablets Cipla?
A: The main benefit is its effectiveness as an oral anticancer agent specifically for Non-Small Cell Lung Cancer, providing a convenient treatment option and reliable efficacy.
Q: When should Gefticip Tablets not be used?
A: Gefticip Tablets should not be used without a prescription and medical supervision. Individuals with known allergies to Gefitinib or related ingredients should consult their doctor before use.
Q: Where is Gefticip Tablets Cipla manufactured and who can supply them?
A: Gefticip Tablets Cipla are manufactured by Cipla in India. They are available for export, supply, and trade through certified suppliers, exporters, and traders specializing in oncological products.
Q: What is the process for placing an order and how is delivery managed?
A: To place an order, contact a certified supplier or exporter. Once payment is received, the order is processed, charged, and the product is handed over to secure couriers for prompt delivery.
Q: What storage instructions should be followed for Gefticip Tablets Cipla?
A: Store Gefticip Tablets below 30C in their original blister pack to maintain effectiveness and shelf life. Avoid exposure to moisture and direct sunlight.